Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism
Ute I Scholl,
Gabriel Stölting,
Carol Nelson-Williams,
Alfred A Vichot,
Murim Choi,
Erin Loring,
Manju L Prasad,
Gerald Goh,
Tobias Carling,
C Christofer Juhlin,
Ivo Quack,
Lars C Rump,
Anne Thiel,
Marc Lande,
Britney G Frazier,
Majid Rasoulpour,
David L Bowlin,
Christine B Sethna,
Howard Trachtman,
Christoph Fahlke,
Richard P Lifton
Affiliations
Ute I Scholl
Department of Genetics, Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, United States; Division of Nephrology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
Institute of Complex Systems, Zelluläre Biophysik, Forschungszentrum Jülich, Jülich, Germany
Carol Nelson-Williams
Department of Genetics, Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, United States
Alfred A Vichot
Department of Genetics, Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, United States
Murim Choi
Department of Genetics, Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, United States; Yale Center for Mendelian Genomics, New Haven, United States
Erin Loring
Department of Genetics, Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, United States; Yale Center for Mendelian Genomics, New Haven, United States
Manju L Prasad
Department of Pathology, Yale University School of Medicine, New Haven, United States
Gerald Goh
Department of Genetics, Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, United States
Tobias Carling
Yale Endocrine Neoplasia Laboratory, Yale School of Medicine, New Haven, United States
C Christofer Juhlin
Yale Endocrine Neoplasia Laboratory, Yale School of Medicine, New Haven, United States; Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Ivo Quack
Division of Nephrology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
Lars C Rump
Division of Nephrology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
Anne Thiel
Division of Nephrology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
Marc Lande
Division of Pediatric Nephrology, University of Rochester Medical Center, Rochester, United States
Britney G Frazier
Madigan Army Medical Center, Tacoma, United States
Majid Rasoulpour
Connecticut Children's Medical Center, Hartford, United States
David L Bowlin
Intermed Consultants Ltd, Edina, United States
Christine B Sethna
Department of Pediatrics, Cohen Children's Medical Center of New York, New Hyde Park, United States
Howard Trachtman
Department of Pediatrics, NYU Langone Medical Center, New York, United States
Christoph Fahlke
Institute of Complex Systems, Zelluläre Biophysik, Forschungszentrum Jülich, Jülich, Germany
Richard P Lifton
Department of Genetics, Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, United States; Yale Center for Mendelian Genomics, New Haven, United States
Many Mendelian traits are likely unrecognized owing to absence of traditional segregation patterns in families due to causation by de novo mutations, incomplete penetrance, and/or variable expressivity. Genome-level sequencing can overcome these complications. Extreme childhood phenotypes are promising candidates for new Mendelian traits. One example is early onset hypertension, a rare form of a global cause of morbidity and mortality. We performed exome sequencing of 40 unrelated subjects with hypertension due to primary aldosteronism by age 10. Five subjects (12.5%) shared the identical, previously unidentified, heterozygous CACNA1HM1549V mutation. Two mutations were demonstrated to be de novo events, and all mutations occurred independently. CACNA1H encodes a voltage-gated calcium channel (CaV3.2) expressed in adrenal glomerulosa. CACNA1HM1549V showed drastically impaired channel inactivation and activation at more hyperpolarized potentials, producing increased intracellular Ca2+, the signal for aldosterone production. This mutation explains disease pathogenesis and provides new insight into mechanisms mediating aldosterone production and hypertension.